B. Riley Wealth Advisors Inc. lessened its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 8.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,614 shares of the technology company’s stock after selling 226 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Veeva Systems were worth $543,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Patriot Financial Group Insurance Agency LLC grew its holdings in Veeva Systems by 0.7% during the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 6,924 shares of the technology company’s stock worth $1,453,000 after acquiring an additional 48 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its holdings in Veeva Systems by 1.2% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,307 shares of the technology company’s stock worth $904,000 after buying an additional 50 shares during the last quarter. Clearbridge Investments LLC boosted its position in shares of Veeva Systems by 0.4% during the 2nd quarter. Clearbridge Investments LLC now owns 11,682 shares of the technology company’s stock worth $2,138,000 after acquiring an additional 52 shares in the last quarter. Park Place Capital Corp increased its holdings in shares of Veeva Systems by 11.5% in the 3rd quarter. Park Place Capital Corp now owns 574 shares of the technology company’s stock valued at $120,000 after acquiring an additional 59 shares during the last quarter. Finally, Quintet Private Bank Europe S.A. raised its position in shares of Veeva Systems by 13.4% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 516 shares of the technology company’s stock worth $108,000 after acquiring an additional 61 shares in the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.
Veeva Systems Trading Down 0.8 %
Shares of VEEV opened at $219.67 on Friday. Veeva Systems Inc. has a twelve month low of $170.25 and a twelve month high of $258.93. The firm has a market capitalization of $35.66 billion, a P/E ratio of 54.24, a PEG ratio of 2.03 and a beta of 0.82. The firm’s 50-day moving average is $222.73 and its two-hundred day moving average is $204.84.
Insider Transactions at Veeva Systems
Analyst Ratings Changes
A number of equities analysts recently issued reports on the company. Needham & Company LLC upped their price target on Veeva Systems from $260.00 to $270.00 and gave the company a “buy” rating in a report on Friday, December 6th. Wells Fargo & Company upped their price objective on shares of Veeva Systems from $275.00 to $285.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Stifel Nicolaus lifted their target price on Veeva Systems from $240.00 to $272.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Morgan Stanley upped their target price on Veeva Systems from $183.00 to $195.00 and gave the company an “underweight” rating in a research report on Tuesday. Finally, Citigroup boosted their price objective on Veeva Systems from $281.00 to $307.00 and gave the company a “buy” rating in a research note on Monday, December 9th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and eighteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $256.58.
Get Our Latest Report on Veeva Systems
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Recommended Stories
- Five stocks we like better than Veeva Systems
- What Does Downgrade Mean in Investing?
- Micron Stock Under $100: Seize the AI-Driven Upside
- How to Evaluate a Stock Before Buying
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What is a Special Dividend?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.